A detailed history of Magnetar Financial LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Magnetar Financial LLC holds 14,623 shares of IOVA stock, worth $84,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,623
Holding current value
$84,520
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$7.17 - $12.28 $104,846 - $179,570
14,623 New
14,623 $108,000
Q2 2024

Aug 14, 2024

BUY
$7.78 - $14.19 $640,784 - $1.17 Million
82,363 New
82,363 $660,000
Q1 2021

May 14, 2021

SELL
$28.67 - $52.59 $258,144 - $473,520
-9,004 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$28.04 - $50.26 $252,472 - $452,541
9,004 New
9,004 $418,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $912M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.